Chromosome 17p13.2 transfer reverts transformation phenotypes and fas‐mediated apoptosis in breast epithelial cells
暂无分享,去创建一个
J. Russo | J. Testa | G. Mor | I. Russo | D. Broccoli | B. Balsara | A. Cuthbert | M. Lareef | Q. Tahin | Joon Song | D. Mihaila | C. Slater | J. Grobelny | Mohamed H. Lareef | Jennifer V. Grobelny
[1] M. Oshimura. Brief Report: Lessons Learned from Studies on Tumor Suppression by Microcell-Mediated Chromosome Transfer , 1991 .
[2] M. Mottolese,et al. Prognostic relevance of altered Fas (CD95)‐system in human breast cancer , 2000, International journal of cancer.
[3] J. Russo,et al. Microsatellite instability during the immortalization and transformation of human breast epithelial cells in vitro , 1999, Molecular carcinogenesis.
[4] Frederick Naftolin,et al. Regulation of Fas ligand expression in breast cancer cells by estrogen: functional differences between estradiol and tamoxifen , 2000, The Journal of Steroid Biochemistry and Molecular Biology.
[5] J. Russo,et al. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. , 1988, Cancer research.
[6] C. Gilks,et al. Chromosomal localization of a gene, GF1, encoding a novel zinc finger protein reveals a new syntenic region between man and rodents. , 1995, Cytogenetics and cell genetics.
[7] J. Russo,et al. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10. , 1990, Cancer research.
[8] K. Tanaka,et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[9] H. Varmus,et al. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation , 1996, Molecular and cellular biology.
[10] T. Soussi,et al. Multifactorial analysis of p53 alteration in human cancer: A review , 1994, International journal of cancer.
[11] T. Khan,et al. Improved artificial death switches based on caspases and FADD. , 1999, Human gene therapy.
[12] J. Hunt. Evaluation of phenotypic alteration by microcell-mediated chromosome transfer. , 1996, Analytical biochemistry.
[13] J. Russo,et al. Differential expression of human ferritin H chain gene in immortal human breast epithelial MCF‐10F cells , 1997, Molecular carcinogenesis.
[14] J. Schlom,et al. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas. , 1986, Cancer research.
[15] G. Calaf,et al. Critical Steps in Breast Carcinogenesis a , 1993, Annals of the New York Academy of Sciences.
[16] J. Palacios,et al. Abnormal frequencies of alleles in polymorphic markers of the 17q21 region is associated with breast cancer. , 1999, Cancer letters.
[17] Alicia Samuels,et al. Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.
[18] B. Ljung,et al. Heterogeneity for allelic loss in human breast cancer. , 1992, Journal of the National Cancer Institute.
[19] W. Dupont,et al. Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy. , 1997, The American journal of pathology.
[20] K. Tartaro,et al. Roles of Fas and Fas ligand during mammary gland remodeling. , 2000, The Journal of clinical investigation.
[21] R. White,et al. Suppression of malignant phenotype in a human prostate cancer cell line by fragments of normal chromosomal region 17q. , 1995, Cancer research.
[22] C. Benjamin,et al. Caspase activation in MCF7 cells responding to etoposide treatment. , 1998, Molecular pharmacology.
[23] B. van Steensel,et al. Structure, subnuclear distribution, and nuclear matrix association of the mammalian telomeric complex , 1996, The Journal of cell biology.
[24] J. Lowenthal,et al. ITA, a vertebrate homologue of IAP that is expressed in T lymphocytes. , 1996, DNA and cell biology.
[25] G. Robertson,et al. A malignant melanoma tumor suppressor on human chromosome 11. , 1996, Cancer research.
[26] D. Birnbaum,et al. BCL-1 participates in the 11q13 amplification found in breast cancer. , 1990, Oncogene.
[27] G. Merlo,et al. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci. , 1989, Oncogene.
[28] R. Callahan,et al. Mutations in human breast cancer: an overview. , 1989, Journal of the National Cancer Institute.
[29] G. Mor,et al. The Fas/Fas‐ligand system: a mechanism for immune evasion in human breast carcinomas , 1999, Breast Cancer Research and Treatment.
[30] M. Oshimura,et al. Metastasis suppressor genes for prostate cancer , 1996, The Prostate. Supplement.
[31] J. Russo,et al. Functional roles of chromosomes 11 and 17 in the transformation of human breast epithelial cells in vitro. , 1999, International journal of oncology.
[32] E. Lam,et al. Characterization and cell cycle-regulated expression of mouse B-myb. , 1992, Oncogene.
[33] S. Kenwrick,et al. A contiguous, 3-Mb physical map of Xq28 extending from the colorblindness locus to DXS15. , 1989, American journal of human genetics.
[34] M. Toi,et al. Circulating soluble Fas concentration in breast cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] A. Asai,et al. Adenovirus-mediated transfer of caspase-3 with Fas ligand induces drastic apoptosis in U-373MG glioma cells. , 2000, Experimental cell research.
[36] J. Russo,et al. A critical approach to the malignant transformation of human breast epithelial cells with chemical carcinogens. , 1993, Critical reviews in oncogenesis.
[37] R. Lidereau,et al. Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Russo,et al. Microsatellite instability and loss of heterozygosity in chromosomes 9 and 16 in human breast epithelial cells transformed by chemical carcinogens. , 1997, Carcinogenesis.
[39] J. Russo,et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. , 1990, Cancer research.
[40] A. Chott,et al. Fas ligand is expressed in normal breast epithelial cells and is frequently up‐regulated in breast cancer , 2000, The Journal of pathology.
[41] W. Dupont,et al. Atypical hyperplastic lesions of the female breast: A long-term follow-up study , 1986 .
[42] M. Oshimura,et al. Genetic regulation of telomerase in a multiple pathways model to cellular senescence. , 1996, Human cell.
[43] M. Oshimura,et al. Mapping of metastasis suppressor gene(s) for rat prostate cancer on the short arm of human chromosome 8 by irradiated microcell‐mediated chromosome transfer , 1996, Genes, chromosomes & cancer.
[44] M. Stratton,et al. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. , 1995, Journal of clinical pathology.
[45] M. Emmert-Buck,et al. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[46] M. J. van de Vijver,et al. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations. , 1994, Cancer research.
[47] M. Genuardi,et al. Distal deletion of chromosome Ip in ductal carcinoma of the breast. , 1989, American journal of human genetics.
[48] M. Oshimura. Lessons learned from studies on tumor suppression by microcell-mediated chromosome transfer. , 1991, Environmental health perspectives.
[49] S. Molineaux,et al. Molecular Cloning and Pro-apoptotic Activity of ICErelII and ICErelIII, Members of the ICE/CED-3 Family of Cysteine Proteases (*) , 1995, The Journal of Biological Chemistry.
[50] B. Agnarsson,et al. Alterations of the FHIT gene in breast cancer: association with tumor progression and patient survival. , 2001, Cancer detection and prevention.
[51] J. Russo,et al. Environmental chemical carcinogens induce transformation of breast epithelial cells from women with familial history of breast cancer , 1997, In Vitro Cellular & Developmental Biology - Animal.
[52] L. Adams,et al. Localization of a growth suppressor activity in MCF7 breast cancer cells to chromosome 17q24-q25 , 1997, Oncogene.
[53] D. Broccoli,et al. Telomerase activity in normal and malignant hematopoietic cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[54] J. Russo,et al. Mini review: Molecular basis of breast cell transformation , 1995 .
[55] A. Forrest,et al. ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS , 1988, The Lancet.
[56] A. Godwin,et al. Identification of two candidate tumor suppressor genes on chromosome 17p13.3. , 1996, Cancer research.
[57] W. Cavenee,et al. Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[58] M. Skolnick,et al. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. , 1992, Cancer research.
[59] R. Lidereau,et al. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[60] Suzanne M Johnson,et al. Sporadic breast cancer in young women: Prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2 , 2002, International journal of cancer.
[61] H. Scherthan,et al. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. , 1995, Oncogene.
[62] C B Harley,et al. Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.
[63] J. Russo,et al. Transformation of human breast epithelial cells by chemical carcinogens. , 1993, Carcinogenesis.
[64] Bas van Steensel,et al. Control of telomere length by the human telomeric protein TRF1 , 1997, Nature.
[65] L. Owen-Schaub,et al. Fas and Fas ligand interactions in malignant disease. , 2000, International journal of oncology.
[66] J. Barrett,et al. Suppression of tumorigenicity in human ovarian carcinoma cell line SKOV-3 by microcell-mediated transfer of chromosome 11. , 2001, Cancer genetics and cytogenetics.
[67] A. Tanigami,et al. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. , 1990, Cancer research.
[68] F. Ruddle,et al. Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[69] L. Chen,et al. Loss of heterozygosity on chromosome 1q in human breast cancer. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[70] J. Russo,et al. Role of Differentiation on Transformation of Human Breast Epithelial Cells , 1987 .
[71] H. Horvitz,et al. The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death. , 1992, Development.
[72] J. Russo,et al. Role of p53 in mcf-10f cell immortalization and chemically-induced neoplastic transformation. , 1995, International journal of oncology.
[73] S. Tsujitani,et al. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma. , 2000, Anticancer research.
[74] R. Ekong,et al. Construction and characterization of a highly stable human: rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. , 1995, Cytogenetics and cell genetics.
[75] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[76] E. Stanbridge,et al. Tumor suppressor genes studied by cell hybridization and chromosome transfer , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[77] Y. Nakamura,et al. Accumulation of genetic alterations and progression of primary breast cancer. , 1991, Cancer research.
[78] J. Bond,et al. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. , 1994, Oncogene.
[79] F. Zhang,et al. Adenoviral vector which delivers FasL–GFP fusion protein regulated by the tet-inducible expression system , 2000, Gene Therapy.
[80] R. Lidereau,et al. Presence of two members of c-erbA receptor gene family (c-erbA beta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma. , 1989, Journal of the National Cancer Institute.